| Literature DB >> 26317540 |
Jan Lüddecke1, Karl Forchhammer1.
Abstract
PII proteins constitute a superfamily of highly conserved signaling devices, common in all domains of life. Through binding of the metabolites ATP, ADP and 2-oxoglutarate (2-OG), they undergo conformational changes which allow them to regulate a variety of target proteins including enzymes, transport proteins and transcription factors. But, in reverse, these target proteins also modulate the metabolite sensing properties of PII, as has been recently shown. We used this effect to refine our PII based Förster resonance energy transfer (FRET) sensor and amplify its sensitivity towards ADP. With this enhanced sensor setup we addressed the question whether the PII protein from the model organism Synechococcus elongatus autonomously switches into the ADP conformation through ATPase activity as proposed in a recently published model. The present study disproves ATPase activity as a relevant mechanism for the transition of PII into the ADP state. In the absence of 2-OG, only the ATP/ADP ratio and concentration of ADP directs the competitive interaction of PII with two targets, one of which preferentially binds PII in the ATP-state, the other in the ADP-state.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26317540 PMCID: PMC4552645 DOI: 10.1371/journal.pone.0137114
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Response of the PII-V NAGK-C FRET sensor towards ADP in the presence of different PipX concentrations.
(A) At a constant ATP concentration of 1 mM the effect of different ADP concentrations on the PII-V NAGK-C FRET was measured in the absence and presence of different PipX concentrations. PII-V and NAGK-C were used in concentrations of 0.1 μM. For practical reasons, the data points representing minimum and maximum values of ADP/ATP ratios where in fact derived from measurements without ADP (using the data point at 0.001 mM ADP) or 10 mM ADP without ATP (using the data point 100 mM ADP). Possible trace amounts of contaminating ADP in the ATP solution were not considered here. Mean values of 3 measurements with standard deviation are shown and a sigmoidal dose response curve was fitted using GraphPad Prism 6. (B) The Hill slope and IC50(ADP) values derived from the fitted curves of Fig 1A are presented with error bars indicating the 95% confidence intervals.
Fig 2Association of PII-V and NAGK-C after PII-V preincubation with and without ATP, measured by FRET.
PII-V (0.1 μM) was either preincubated with 10 μM ATP (solid line) or without ATP (dashed line) for 30 min at 37°C. The FRET measurement was started and after 0.5 min NAGK-C (0.1 μM) was added. In the control experiment ATP (10 μM) was added together with NAGK-C.
Fig 3Measuring the ADP production by PII.
A: PII-V was incubated with ATP for 1 h at 37°C, then NAGK-C and PipX were added and FRET was measured after 15 min of additional incubation. B: PII-V was incubated without ATP for 1 h at 37°C, then ATP, NAGK-C and PipX were added and FRET was measured after 15 min of additional incubation. C: PII-V was incubated without ATP for 1 h at 37°C, then a mixture of ATP, ADP, NAGK-C and PipX was added and FRET was measured after 15 min of additional incubation. Used concentrations: PII-V, NAGK-C: 0.1 μM, PipX: 1 μM; ATP (A, B): 10 μM (dark blue), 100 μM (blue), 1000 μM (light blue); ATP+ADP mixture (C): 5 μM each (dark blue), 50 μM each (blue) 500 μM each (light blue). Mean values of 3 experiments with standard deviation are shown.